Ramzi M. Mohammad

2.7k total citations
74 papers, 1.9k citations indexed

About

Ramzi M. Mohammad is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ramzi M. Mohammad has authored 74 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 41 papers in Oncology and 13 papers in Genetics. Recurrent topics in Ramzi M. Mohammad's work include Cancer-related Molecular Pathways (19 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Lymphoma Diagnosis and Treatment (10 papers). Ramzi M. Mohammad is often cited by papers focused on Cancer-related Molecular Pathways (19 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Lymphoma Diagnosis and Treatment (10 papers). Ramzi M. Mohammad collaborates with scholars based in United States, Qatar and United Kingdom. Ramzi M. Mohammad's co-authors include Ayad Al‐Katib, Asfar S. Azmi, George R. Pettit, Fazlul H. Sarkar, Nathan R. Wall, Andrea König, Janice Gabrilove, Gary K. Schwartz, Amro Aboukameel and Philip A. Philip and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ramzi M. Mohammad

73 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramzi M. Mohammad United States 28 1.1k 788 249 216 194 74 1.9k
Hirohisa Tsujinoue Japan 25 1.1k 1.0× 460 0.6× 455 1.8× 200 0.9× 161 0.8× 50 2.6k
Clint Mitchell United States 30 1.6k 1.5× 846 1.1× 192 0.8× 174 0.8× 134 0.7× 43 2.5k
Tomohisa Yokoyama Japan 22 1.1k 1.0× 450 0.6× 269 1.1× 141 0.7× 134 0.7× 44 2.0k
Muxiang Zhou United States 26 1.6k 1.5× 893 1.1× 525 2.1× 119 0.6× 118 0.6× 51 2.3k
Brandon J. Aubrey Australia 10 1.2k 1.1× 568 0.7× 328 1.3× 143 0.7× 101 0.5× 17 1.8k
Takeshi Iwamura Japan 22 1.1k 1.0× 697 0.9× 444 1.8× 115 0.5× 67 0.3× 44 2.0k
Chunrong Yu United States 33 2.2k 2.0× 669 0.8× 348 1.4× 273 1.3× 281 1.4× 49 3.0k
Babita Madan Singapore 27 1.7k 1.5× 730 0.9× 219 0.9× 162 0.8× 211 1.1× 50 2.5k
Wei Cui United States 22 939 0.9× 519 0.7× 356 1.4× 213 1.0× 125 0.6× 86 1.8k
Amro Aboukameel United States 31 2.0k 1.8× 1.0k 1.3× 611 2.5× 226 1.0× 151 0.8× 91 2.8k

Countries citing papers authored by Ramzi M. Mohammad

Since Specialization
Citations

This map shows the geographic impact of Ramzi M. Mohammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramzi M. Mohammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramzi M. Mohammad more than expected).

Fields of papers citing papers by Ramzi M. Mohammad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramzi M. Mohammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramzi M. Mohammad. The network helps show where Ramzi M. Mohammad may publish in the future.

Co-authorship network of co-authors of Ramzi M. Mohammad

This figure shows the co-authorship network connecting the top 25 collaborators of Ramzi M. Mohammad. A scholar is included among the top collaborators of Ramzi M. Mohammad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramzi M. Mohammad. Ramzi M. Mohammad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Husain Yar, Misako Nagasaka, Amro Aboukameel, et al.. (2023). Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRAS G12C-Mutant Pancreatic and Lung Cancers. Molecular Cancer Therapeutics. 22(12). 1422–1433. 5 indexed citations
2.
Khan, Husain Yar, Misako Nagasaka, Yiwei Li, et al.. (2022). Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers. Cancer Research Communications. 2(5). 342–352. 21 indexed citations
3.
Siveen, Kodappully Sivaraman, Kirti S. Prabhu, Roopesh Krishnankutty, et al.. (2017). Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges. Current Vascular Pharmacology. 15(4). 339–351. 174 indexed citations
4.
Liu, Shuang, Guan Wang, Holly Edwards, et al.. (2017). Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer. Oncotarget. 8(27). 44295–44311. 23 indexed citations
5.
6.
Azmi, Asfar S., Ayad Al‐Katib, Amro Aboukameel, et al.. (2011). Development of a Novel Small Molecule CRM-1 Inhibitor for Non Hodgkin's Lymphoma. Blood. 118(21). 598–598. 3 indexed citations
7.
Azmi, Asfar S., Frances W.J. Beck, Fazlul H. Sarkar, & Ramzi M. Mohammad. (2011). Network Perspectives on HDM2 Inhibitor Chemotherapy Combinations. Current Pharmaceutical Design. 17(6). 640–652. 6 indexed citations
8.
Nautiyal, Jyoti, Yingjie Yu, Amro Aboukameel, et al.. (2010). ErbB-Inhibitory Protein: A Modified Ectodomain of Epidermal Growth Factor Receptor Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells. Molecular Cancer Therapeutics. 9(6). 1503–1514. 9 indexed citations
9.
Levi, Edi, Liyue Zhang, Amro Aboukameel, et al.. (2010). Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor. Cancer Chemotherapy and Pharmacology. 67(6). 1401–1413. 4 indexed citations
10.
Azmi, Asfar S., P. A. Philip, Khaldoun Almhanna, et al.. (2010). MDM2 Inhibitors for Pancreatic Cancer Therapy. Mini-Reviews in Medicinal Chemistry. 10(6). 518–526. 5 indexed citations
11.
Wang, Zhiwei, Asfar S. Azmi, Aamir Ahmad, et al.. (2009). TW-37, a Small-Molecule Inhibitor of Bcl-2, Inhibits Cell Growth and Induces Apoptosis in Pancreatic Cancer: Involvement of Notch-1 Signaling Pathway. Cancer Research. 69(7). 2757–2765. 69 indexed citations
12.
Heng, Henry H., et al.. (2005). Characterization of three pairs of prostate cells lines derived from tumor and adjacent normal tissues. Cancer Research. 65. 462–462. 2 indexed citations
13.
Levi, Edi, Ramzi M. Mohammad, Sudha Reddy, et al.. (2004). EGF-receptor related protein causes cell cycle arrest and induces apoptosis of colon cancer cells in vitro and in vivo.. PubMed. 24(5A). 2885–91. 12 indexed citations
14.
15.
Roman, Viviana, Christian Billard, Catherine Kern, et al.. (2002). Analysis of resveratrol‐induced apoptosis in human B‐cell chronic leukaemia. British Journal of Haematology. 117(4). 842–851. 72 indexed citations
16.
Mohammad, Ramzi M., Volkan Adsay, Philip A. Philip, et al.. (2001). Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model. Anti-Cancer Drugs. 12(9). 735–740. 11 indexed citations
17.
Wall, Nathan R., Ramzi M. Mohammad, & Ayad Al‐Katib. (2001). Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh.. PubMed. 12(12). 641–7. 12 indexed citations
18.
Mohammad, Ramzi M., et al.. (1998). Synergistic interaction of selected marine animal anticancer drugs against human diffuse large cell lymphoma. Anti-Cancer Drugs. 9(2). 149–156. 18 indexed citations
19.
Mohammad, Ramzi M., et al.. (1995). Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma. Leukemia Research. 19(9). 667–673. 49 indexed citations
20.
Al‐Katib, Ayad, Ramzi M. Mohammad, Anwar N. Mohamed, George R. Pettit, & Lyle L. Sensenbrenner. (1990). Conversion of high grade lymphoma tumor cell line to intermediate grade with tpa and bryostatin 1 as determined by polypeptide analysis on 2D gel electrophoresis. Hematological Oncology. 8(2). 81–89. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirohisa Tsujinoue Breakdown of academic impact, for papers by Clint Mitchell Breakdown of academic impact, for papers by Tomohisa Yokoyama Breakdown of academic impact, for papers by Muxiang Zhou Breakdown of academic impact, for papers by Brandon J. Aubrey Breakdown of academic impact, for papers by Takeshi Iwamura Breakdown of academic impact, for papers by Chunrong Yu Breakdown of academic impact, for papers by Babita Madan Breakdown of academic impact, for papers by Wei Cui Breakdown of academic impact, for papers by Amro Aboukameel
Rankless by CCL
2026